RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 76 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,058,000 | +116.3% | 340,909 | +29.5% | 0.00% | +100.0% |
| Q2 2016 | $1,414,000 | +2.8% | 263,274 | -12.0% | 0.00% | 0.0% |
| Q1 2016 | $1,376,000 | -9.6% | 299,098 | +2.2% | 0.00% | 0.0% |
| Q4 2015 | $1,522,000 | -11.2% | 292,620 | +3.3% | 0.00% | -33.3% |
| Q3 2015 | $1,714,000 | -59.4% | 283,266 | +6.0% | 0.00% | -50.0% |
| Q2 2015 | $4,220,000 | +75.4% | 267,245 | +20.8% | 0.01% | +100.0% |
| Q1 2015 | $2,406,000 | +8.2% | 221,280 | +4.7% | 0.00% | 0.0% |
| Q4 2014 | $2,223,000 | +26.7% | 211,296 | +15.5% | 0.00% | 0.0% |
| Q3 2014 | $1,755,000 | -15.3% | 182,944 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $2,072,000 | +22.2% | 179,360 | +5.8% | 0.00% | 0.0% |
| Q1 2014 | $1,696,000 | -4.9% | 169,562 | +23.8% | 0.00% | 0.0% |
| Q4 2013 | $1,784,000 | -6.3% | 136,954 | +8.0% | 0.00% | -25.0% |
| Q3 2013 | $1,903,000 | +75.9% | 126,802 | +10.8% | 0.00% | +100.0% |
| Q2 2013 | $1,082,000 | – | 114,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |